Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera

Haematologica

Volumn 96, Issue 5, 2011, Pages 775-778

  Swierczek, Sabina I ^a   Yoon, Donghoon ^a   Bellanné Chantelot, Christine ^b,c   Kim, Soo Jin ^a   Saint Martin, Cécile ^b,c   Delhommeau, Francois ^d   Najman, Albert ^d   Prchal, Josef T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Universite Paris Sud   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Polycythemia vera; TET2 mutations

Indexed keywords

CD34 ANTIGEN;

ALLELE; ARTICLE; CELL CLONE; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; FEMALE; GENE; GENE MUTATION; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; JAK2 GENE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; POLYCYTHEMIA VERA; RETICULOCYTE; SOMATIC MUTATION; T LYMPHOCYTE; TET2 GENE; THROMBOCYTE; X CHROMOSOME;

AMINO ACID SUBSTITUTION; BLOOD PLATELETS; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, X; CLONE CELLS; DNA-BINDING PROTEINS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HEMATOPOIETIC SYSTEM; HUMANS; JANUS KINASE 2; MUTATION; POLYCYTHEMIA VERA; PROTO-ONCOGENE PROTEINS; RETICULOCYTES; T-LYMPHOCYTES; TIME FACTORS;

EID: 79955743876     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.029678     Document Type: Article

References (14)

1. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289-301.
2. Schaub FX, Looser R, Li S, Hao-Shen H, Lehmann T, Tichelli A, et al. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood. 2010;115(10):2003-7.
3. Saint-Martin C, Leroy G, Delhommeau F, Panelatti G, Dupont S, James C, et al. Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood. 2009;114(8):1628-32.
4. Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, et al. TET2 mutations and their clinical correlates in polycythemia vera, essential hrombocythemia and myelofibrosis. Leukemia. 2009;23(5):905-11.
5. Kralovics R, Teo SS, Li S, Theocharides A, Buser AS, Tichelli A, et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood. 2006;108(4):1377-80.
6. Nussenzveig RH, Swierczek SI, Jelinek J, Gaikwad A, Liu E, Verstovsek S, et al. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol. 2007;35(1):32-8.
7. Kralovics R, Guan Y, Prchal JT. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol. 2002;30(3):229-36.
8. Swierczek SI, Agarwal N, Nussenzveig RH, Rothstein G, Wilson A, Artz A, et al. Hematopoiesis is not clonal in healthy elderly women. Blood. 2008;112(8):3186-93.
9. Chen GL, Prchal JT. X-linked clonality testing: interpretation and limitations. Blood. 2007;110(5):1411-9.
10. Prchal JT, Prchal JF, Belickova M, Chen S, Guan Y, Gartland GL, et al. Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med. 1996;183(2):561-7.
11. Kralovics R, Stockton DW, Prchal JT. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood. 2003; 102(10):3793-6.
12. Bruchova H, Yoon D, Agarwal AM, Swierczek S, Prchal JT. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation. Blood Cells Mol Dis. 2009;43(1):81-7.
13. Gaikwad A, Nussenzveig R, Liu E, Gottshalk S, Chang K, Prchal JT. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele. Exp Hematol. 2007;35(4):587-95.
14. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Muhlemann O. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci. 2010;67(5):677-700.